Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 18.98
-0.48 (-2.47%)
At close: Jul 29, 2026
Frontier Biotechnologies Market Cap
Frontier Biotechnologies has a market cap or net worth of 7.29 billion as of July 29, 2026. Its market cap has decreased by -0.36% in one year.
Market Cap
7.29B
Enterprise Value
7.03B
Revenue
392.19M
Ranking
n/a
PE Ratio
2,105.37
Stock Price
18.98
ChartMarket Cap Chart
Since October 28, 2020, Frontier Biotechnologies's market cap has decreased from 10.76B to 7.29B, a decrease of -32.26%. That is a compound annual growth rate of -6.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 7.29B | 7.81% |
| Dec 31, 2025 | 6.76B | 84.94% |
| Dec 31, 2024 | 3.66B | -1.61% |
| Dec 29, 2023 | 3.72B | -42.53% |
| Dec 30, 2022 | 6.47B | -3.33% |
| Dec 31, 2021 | 6.69B | -3.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Hisoar Pharmaceutical | 7.87B |
| Beijing Foyou Pharma CO.,LTD | 7.66B |
| Sunflower Pharmaceutical Group | 7.61B |
| Shanghai Yizhong Pharmaceutical | 7.61B |
| Guilin Sanjin Pharmaceutical | 7.55B |
| Shandong Lukang Pharmaceutical | 7.42B |
| Jiuzhitang | 7.40B |
| Hubei Hongyuan Pharmaceutical Technology | 7.34B |